GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $85,096 | +112.7% | 40,522 | +14.5% | 0.00% | – |
| Q4 2022 | $40,000 | -54.0% | 35,398 | -15.9% | 0.00% | – |
| Q4 2021 | $87,000 | -52.5% | 42,100 | -10.6% | 0.00% | – |
| Q3 2021 | $183,000 | +140.8% | 47,100 | +98.5% | 0.00% | – |
| Q2 2021 | $76,000 | -13.6% | 23,733 | -0.5% | 0.00% | – |
| Q3 2019 | $88,000 | -22.1% | 23,849 | +8.3% | 0.00% | – |
| Q1 2019 | $113,000 | +24.2% | 22,029 | +53.3% | 0.00% | – |
| Q2 2018 | $91,000 | -65.5% | 14,369 | -24.8% | 0.00% | -100.0% |
| Q2 2014 | $264,000 | +29.4% | 19,096 | +43.0% | 0.00% | +50.0% |
| Q1 2014 | $204,000 | – | 13,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
| Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
| Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
| CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
| WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
| D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
| Virtu Financial LLC | 14,683 | $32,000 | 0.00% |